Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1,340 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $1,340 | 10 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $75.90 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($75.90) |
| 2017 | $1,264 | 9 | Bayer HealthCare Pharmaceuticals Inc. ($1,264) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/30/2018 | Bayer HealthCare Pharmaceuticals Inc. | Xarelto (Drug) | — | Cash or cash equivalent | $75.90 | Research |
| Study: BAY59-7939Tx and sec prev of acute VTE vs SOC in pediatric • Category: Cardio-pulmonary | ||||||
| 10/25/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xarelto (Drug) | — | Cash or cash equivalent | $168.38 | Research |
| Study: BAY59 7939 Tx and sec prev of acute VTE vs SOC in pediatric • Category: Cardio-pulmonary | ||||||
| 09/28/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xarelto (Drug) | — | Cash or cash equivalent | $201.03 | Research |
| Study: BAY59 7939 Tx and sec prev of acute VTE vs SOC in pediatric • Category: Cardio-pulmonary | ||||||
| 09/28/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xarelto (Drug) | — | Cash or cash equivalent | $161.14 | Research |
| Study: BAY59 7939 Tx and sec prev of acute VTE vs SOC in pediatric • Category: Cardio-pulmonary | ||||||
| 09/28/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xarelto (Drug) | — | Cash or cash equivalent | $64.13 | Research |
| Study: BAY59 7939 Tx and sec prev of acute VTE vs SOC in pediatric • Category: Cardio-pulmonary | ||||||
| 09/28/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xarelto (Drug) | — | Cash or cash equivalent | $49.43 | Research |
| Study: BAY59 7939 Tx and sec prev of acute VTE vs SOC in pediatric • Category: Cardio-pulmonary | ||||||
| 09/28/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xarelto (Drug) | — | Cash or cash equivalent | $33.40 | Research |
| Study: BAY59 7939 Tx and sec prev of acute VTE vs SOC in pediatric • Category: Cardio-pulmonary | ||||||
| 09/28/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xarelto (Drug) | — | Cash or cash equivalent | $29.39 | Research |
| Study: BAY59 7939 Tx and sec prev of acute VTE vs SOC in pediatric • Category: Cardio-pulmonary | ||||||
| 09/07/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xarelto (Drug) | — | Cash or cash equivalent | $384.15 | Research |
| Study: BAY59 7939 Tx and sec prev of acute VTE vs SOC in pediatric • Category: Cardio-pulmonary | ||||||
| 03/06/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xarelto (Drug) | — | Cash or cash equivalent | $172.91 | Research |
| Study: BAY59 7939 Ph II 4 wk safety and PK PD study in pediatric • Category: Cardio-pulmonary | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| BAY59 7939 Tx and sec prev of acute VTE vs SOC in pediatric | Bayer HealthCare Pharmaceuticals Inc. | $1,091 | 8 |
| BAY59 7939 Ph II 4 wk safety and PK PD study in pediatric | Bayer HealthCare Pharmaceuticals Inc. | $172.91 | 1 |
| BAY59-7939Tx and sec prev of acute VTE vs SOC in pediatric | Bayer HealthCare Pharmaceuticals Inc. | $75.90 | 1 |
About Dr. Rukhmi Bhat, MD
Dr. Rukhmi Bhat, MD is a Pediatric Hematology-Oncology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2008. The National Provider Identifier (NPI) number assigned to this provider is 1326204819.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rukhmi Bhat, MD has received a total of $1,340 in payments from pharmaceutical and medical device companies, with $75.90 received in 2018. These payments were reported across 10 transactions from 1 company. The most common payment nature is "" ($1,340).
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Chicago, IL
- Active Since 08/04/2008
- Last Updated 08/04/2008
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1326204819
Products in Payments
- Xarelto (Drug) $1,340
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Chicago
Alexis Thompson, Md, MD
Pediatric Hematology-Oncology — Payments: $1.6M
James Labelle
Pediatric Hematology-Oncology — Payments: $249,251
Sherif Badawy, Md, MD
Pediatric Hematology-Oncology — Payments: $207,866
Dr. Loretta Li, M.d, M.D
Pediatric Hematology-Oncology — Payments: $187,559
Susan Cohn
Pediatric Hematology-Oncology — Payments: $125,685
Leonard Valentino, M.d, M.D
Pediatric Hematology-Oncology — Payments: $117,453